Quan, Lili
Ohgaki, Ryuichi
Hara, Saori
Okuda, Suguru
Wei, Ling
Okanishi, Hiroki
Nagamori, Shushi
Endou, Hitoshi
Kanai, Yoshikatsu http://orcid.org/0000-0001-8126-286X
Funding for this research was provided by:
Pharmacological Research Foundation, Tokyo
JSPS Grant-in-Aid for Scientific Research (18K06931)
JSPS Grants-in-Aid for Scientific Research (19H03407)
Project for Cancer Research And Therapeutic Evolution from AMED (JP17cm0106118, JP18cm0106131, JP19cm0106151, JP20cm0106151)
Advanced Research for Medical Products Mining Program of NIBIO (12-02)
Translational Research Network Program from MEXT (H25B7)
Collaborative Research Grant from J-Pharma Co., Ltd.
Article History
Received: 31 August 2020
Accepted: 3 November 2020
First Online: 30 November 2020
Ethics approval and consent to participate
: Animal experiments were conducted in compliance with the protocols approved by the Osaka University Medical School Animal Care and Use Committee.
: No applicable.
: Y.K. received collaborative research grant from J-Pharma Co., Ltd. H.E. is Founder of J-Pharma Co., Ltd. and has led the development of JPH203. Other authors declare no competing interests.